Any way you like Wilson, but I'm also assuming your statement of "ANP has always delivered under budget and on time or before in the past, and I expect that to remain the case" is based on what ? A relatively straight forward Phase I study to demonstrate safety & tolerability ? It's probably wise to look a bit more in depth when ou claim you'll "put money on that not happening". It's not a dig at ANP inparticular but the comment regarding doubling estimates & adding 12 months to timeframes comes into play much more often you would think. Even look at ANP in the past with comparitive stage trials look at ATL1102 Phase IIa that didn't reach completion until 12 months after inital guidance was given & would of in turn increased expenses to reflect that. Dosing commenced in June 2006 with results finally deliverd in June 2008 after repeatedly extending the time frames from Q2 2007.
ANP Price at posting:
15.0¢ Sentiment: None Disclosure: Held
